Home Healthcare IT Myasthenia Gravis Treatment Market Size, Share & Trends | Industry Report, 2033

Myasthenia Gravis Treatment Market Size & Outlook, 2025-2033

Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report By Type (Ocular MG, Congenital MG, Transient Neonatal MG), By Treatment (Medication, Surgery, Autologous Hematopoietic Stem Cell Transplantation (HSCT), Plasmapheresis and Intravenous Immunoglobulin, Others), By End-User (Hospitals, Clinics, Academic Research Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI159DR
Last Updated : Sep, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. Myasthenia Gravis Treatment Market, By Type (2021-2033)
    1. Ocular MG 
    2. Congenital MG 
    3. Transient Neonatal MG
  2. Myasthenia Gravis Treatment Market, By Treatment (2021-2033)
    1. Medication 
    2. Surgery 
    3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
    4. Plasmapheresis and Intravenous Immunoglobulin 
    5. Others
  3. Myasthenia Gravis Treatment Market, By End-User (2021-2033)
    1. Hospitals 
    2. Clinics 
    3. Academic Research Institutes 
    4. Others
    1. North America
      1. North America Myasthenia Gravis Treatment Market, By Type
        1. Ocular MG 
          1. Congenital MG 
            1. Transient Neonatal MG
            2. North America Myasthenia Gravis Treatment Market, By Treatment
              1. Medication 
                1. Surgery 
                  1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                    1. Plasmapheresis and Intravenous Immunoglobulin 
                      1. Others
                      2. North America Myasthenia Gravis Treatment Market, By End-User
                        1. Hospitals 
                          1. Clinics 
                            1. Academic Research Institutes 
                              1. Others
                              2. U.S.
                                1. U.S. Myasthenia Gravis Treatment Market, By Type
                                  1. Ocular MG 
                                    1. Congenital MG 
                                      1. Transient Neonatal MG
                                      2. U.S. Myasthenia Gravis Treatment Market, By Treatment
                                        1. Medication 
                                          1. Surgery 
                                            1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                              1. Plasmapheresis and Intravenous Immunoglobulin 
                                                1. Others
                                                2. U.S. Myasthenia Gravis Treatment Market, By End-User
                                                  1. Hospitals 
                                                    1. Clinics 
                                                      1. Academic Research Institutes 
                                                        1. Others
                                                      2. Canada
                                                    2. Europe
                                                      1. Europe Myasthenia Gravis Treatment Market, By Type
                                                        1. Ocular MG 
                                                          1. Congenital MG 
                                                            1. Transient Neonatal MG
                                                            2. Europe Myasthenia Gravis Treatment Market, By Treatment
                                                              1. Medication 
                                                                1. Surgery 
                                                                  1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                    1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                      1. Others
                                                                      2. Europe Myasthenia Gravis Treatment Market, By End-User
                                                                        1. Hospitals 
                                                                          1. Clinics 
                                                                            1. Academic Research Institutes 
                                                                              1. Others
                                                                              2. U.K.
                                                                                1. U.K. Myasthenia Gravis Treatment Market, By Type
                                                                                  1. Ocular MG 
                                                                                    1. Congenital MG 
                                                                                      1. Transient Neonatal MG
                                                                                      2. U.K. Myasthenia Gravis Treatment Market, By Treatment
                                                                                        1. Medication 
                                                                                          1. Surgery 
                                                                                            1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                                              1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                                                1. Others
                                                                                                2. U.K. Myasthenia Gravis Treatment Market, By End-User
                                                                                                  1. Hospitals 
                                                                                                    1. Clinics 
                                                                                                      1. Academic Research Institutes 
                                                                                                        1. Others
                                                                                                      2. Germany
                                                                                                      3. France
                                                                                                      4. Spain
                                                                                                      5. Italy
                                                                                                      6. Russia
                                                                                                      7. Nordic
                                                                                                      8. Benelux
                                                                                                      9. Rest of Europe
                                                                                                    2. APAC
                                                                                                      1. APAC Myasthenia Gravis Treatment Market, By Type
                                                                                                        1. Ocular MG 
                                                                                                          1. Congenital MG 
                                                                                                            1. Transient Neonatal MG
                                                                                                            2. APAC Myasthenia Gravis Treatment Market, By Treatment
                                                                                                              1. Medication 
                                                                                                                1. Surgery 
                                                                                                                  1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                                                                    1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                                                                      1. Others
                                                                                                                      2. APAC Myasthenia Gravis Treatment Market, By End-User
                                                                                                                        1. Hospitals 
                                                                                                                          1. Clinics 
                                                                                                                            1. Academic Research Institutes 
                                                                                                                              1. Others
                                                                                                                              2. China
                                                                                                                                1. China Myasthenia Gravis Treatment Market, By Type
                                                                                                                                  1. Ocular MG 
                                                                                                                                    1. Congenital MG 
                                                                                                                                      1. Transient Neonatal MG
                                                                                                                                      2. China Myasthenia Gravis Treatment Market, By Treatment
                                                                                                                                        1. Medication 
                                                                                                                                          1. Surgery 
                                                                                                                                            1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                                                                                              1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                                                                                                1. Others
                                                                                                                                                2. China Myasthenia Gravis Treatment Market, By End-User
                                                                                                                                                  1. Hospitals 
                                                                                                                                                    1. Clinics 
                                                                                                                                                      1. Academic Research Institutes 
                                                                                                                                                        1. Others
                                                                                                                                                      2. Korea
                                                                                                                                                      3. Japan
                                                                                                                                                      4. India
                                                                                                                                                      5. Australia
                                                                                                                                                      6. Singapore
                                                                                                                                                      7. Taiwan
                                                                                                                                                      8. South East Asia
                                                                                                                                                      9. Rest of Asia-Pacific
                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                      1. Middle East and Africa Myasthenia Gravis Treatment Market, By Type
                                                                                                                                                        1. Ocular MG 
                                                                                                                                                          1. Congenital MG 
                                                                                                                                                            1. Transient Neonatal MG
                                                                                                                                                            2. Middle East and Africa Myasthenia Gravis Treatment Market, By Treatment
                                                                                                                                                              1. Medication 
                                                                                                                                                                1. Surgery 
                                                                                                                                                                  1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                                                                                                                    1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                                                                                                                      1. Others
                                                                                                                                                                      2. Middle East and Africa Myasthenia Gravis Treatment Market, By End-User
                                                                                                                                                                        1. Hospitals 
                                                                                                                                                                          1. Clinics 
                                                                                                                                                                            1. Academic Research Institutes 
                                                                                                                                                                              1. Others
                                                                                                                                                                              2. UAE
                                                                                                                                                                                1. UAE Myasthenia Gravis Treatment Market, By Type
                                                                                                                                                                                  1. Ocular MG 
                                                                                                                                                                                    1. Congenital MG 
                                                                                                                                                                                      1. Transient Neonatal MG
                                                                                                                                                                                      2. UAE Myasthenia Gravis Treatment Market, By Treatment
                                                                                                                                                                                        1. Medication 
                                                                                                                                                                                          1. Surgery 
                                                                                                                                                                                            1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                                                                                                                                              1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                                                                                                                                                1. Others
                                                                                                                                                                                                2. UAE Myasthenia Gravis Treatment Market, By End-User
                                                                                                                                                                                                  1. Hospitals 
                                                                                                                                                                                                    1. Clinics 
                                                                                                                                                                                                      1. Academic Research Institutes 
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                      1. LATAM Myasthenia Gravis Treatment Market, By Type
                                                                                                                                                                                                        1. Ocular MG 
                                                                                                                                                                                                          1. Congenital MG 
                                                                                                                                                                                                            1. Transient Neonatal MG
                                                                                                                                                                                                            2. LATAM Myasthenia Gravis Treatment Market, By Treatment
                                                                                                                                                                                                              1. Medication 
                                                                                                                                                                                                                1. Surgery 
                                                                                                                                                                                                                  1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                                                                                                                                                                    1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                      2. LATAM Myasthenia Gravis Treatment Market, By End-User
                                                                                                                                                                                                                        1. Hospitals 
                                                                                                                                                                                                                          1. Clinics 
                                                                                                                                                                                                                            1. Academic Research Institutes 
                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                              2. Brazil
                                                                                                                                                                                                                                1. Brazil Myasthenia Gravis Treatment Market, By Type
                                                                                                                                                                                                                                  1. Ocular MG 
                                                                                                                                                                                                                                    1. Congenital MG 
                                                                                                                                                                                                                                      1. Transient Neonatal MG
                                                                                                                                                                                                                                      2. Brazil Myasthenia Gravis Treatment Market, By Treatment
                                                                                                                                                                                                                                        1. Medication 
                                                                                                                                                                                                                                          1. Surgery 
                                                                                                                                                                                                                                            1. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
                                                                                                                                                                                                                                              1. Plasmapheresis and Intravenous Immunoglobulin 
                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                2. Brazil Myasthenia Gravis Treatment Market, By End-User
                                                                                                                                                                                                                                                  1. Hospitals 
                                                                                                                                                                                                                                                    1. Clinics 
                                                                                                                                                                                                                                                      1. Academic Research Institutes 
                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                  Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                  Get This Report

                                                                                                                                                                                                                                                  Download Free Sample

                                                                                                                                                                                                                                                  Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                  The button will be active once the above form is filled

                                                                                                                                                                                                                                                  Our Clients:

                                                                                                                                                                                                                                                  LG Electronics
                                                                                                                                                                                                                                                  AMCAD Engineering
                                                                                                                                                                                                                                                  KOBE STEEL LTD.
                                                                                                                                                                                                                                                  Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                  Voith Group
                                                                                                                                                                                                                                                  International Paper
                                                                                                                                                                                                                                                  Hansol Paper
                                                                                                                                                                                                                                                  Whirlpool Corporation
                                                                                                                                                                                                                                                  Sony
                                                                                                                                                                                                                                                  Samsung Electronics
                                                                                                                                                                                                                                                  Qualcomm
                                                                                                                                                                                                                                                  Google
                                                                                                                                                                                                                                                  Fiserv
                                                                                                                                                                                                                                                  Veto-Pharma
                                                                                                                                                                                                                                                  Nippon Becton Dickinson
                                                                                                                                                                                                                                                  Merck
                                                                                                                                                                                                                                                  Argon Medical Devices
                                                                                                                                                                                                                                                  Abbott
                                                                                                                                                                                                                                                  Ajinomoto
                                                                                                                                                                                                                                                  Denon
                                                                                                                                                                                                                                                  Doosan
                                                                                                                                                                                                                                                  Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                  LG Chemicals
                                                                                                                                                                                                                                                  LCY chemical group
                                                                                                                                                                                                                                                  Bayer
                                                                                                                                                                                                                                                  Airrane
                                                                                                                                                                                                                                                  BASF
                                                                                                                                                                                                                                                  Toyota Industries
                                                                                                                                                                                                                                                  Nissan Motors
                                                                                                                                                                                                                                                  Neenah
                                                                                                                                                                                                                                                  Mitsubishi
                                                                                                                                                                                                                                                  Hyundai Motor Company

                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                  Address:
                                                                                                                                                                                                                                                  Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                  Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                  Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                  Contact Us:
                                                                                                                                                                                                                                                  +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                  +91 8087085354 (India)
                                                                                                                                                                                                                                                  +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                  sales@straitsresearch.com

                                                                                                                                                                                                                                                  Quick Links
                                                                                                                                                                                                                                                  Help
                                                                                                                                                                                                                                                  Verified. Protected. Secure.
                                                                                                                                                                                                                                                  DMCA.com Protection Status
                                                                                                                                                                                                                                                  Secure Payments:
                                                                                                                                                                                                                                                  Follow Us:
                                                                                                                                                                                                                                                  www.straitsresearch.com © Copyright . All rights Reserved.